|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash deposits | |||||||||||||||
| Trade receivables (net of allowance for credit losses of $139 and $79 at December 31, 2025 and 2024, respectively) | |||||||||||||||
| Other receivable and prepaid expenses | |||||||||||||||
| Inventories | |||||||||||||||
| Total current assets | |||||||||||||||
| PROPERTY AND EQUIPMENT, NET | |||||||||||||||
| OTHER LONG TERM ASSETS: | |||||||||||||||
| Other assets | |||||||||||||||
| Long term assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||
| Deferred tax assets | |||||||||||||||
| Other intangible assets, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Total assets | |||||||||||||||
| CURRENT LIABILITIES: | |||||||||||||||
| Short-term bank loans | |||||||||||||||
| Short term loan and Current maturities of long-term loans | |||||||||||||||
| Operating lease liabilities, current | |||||||||||||||
| Trade payables | |||||||||||||||
| Employees and payroll accruals | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Advances net of inventory in progress | |||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Long-term loans, net of current maturities | |||||||||||||||
| Operating lease liabilities, non-current | |||||||||||||||
| Long-term deferred revenues | |||||||||||||||
| Accrued severance pay | |||||||||||||||
| Total long-term liabilities | |||||||||||||||
| SHAREHOLDERS’ EQUITY: | |||||||||||||||
| Share capital: | |||||||||||||||
| Ordinary Shares: Authorized; 11,000,000 shares at December 31, 2025 and 2024, respectively; Issued and outstanding: 7,028,934 and : 5,792,559 shares at December 31, 2025 and 2024, respectively and additional paid-in capital | |||||||||||||||
| Shares to be issued | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total shareholders’ equity | |||||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||||
Loading...